IDEXX (NASDAQ: IDXX) director Bruce Claflin granted deferred stock units and options
Rhea-AI Filing Summary
IDEXX Laboratories director Bruce L. Claflin received new equity awards as part of his board compensation. He was granted 234 deferred stock units, each representing a contingent right to receive one share of common stock, bringing his deferred stock unit balance to 1,354 units.
He was also granted 525 non-qualified stock options to buy common stock at an exercise price of $533.9200 per share, all held directly. Both the options and deferred stock units vest in one installment on the one-year anniversary of the grant date or on the date of the 2027 annual meeting of shareholders, whichever occurs earlier. The deferred stock units are, by default, payable in common stock after his resignation from the board.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Claflin Bruce L.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Qualified Stock Option (right-to-buy) | 525 | $0.00 | $0.00 |
| Grant/Award | Deferred Stock Unit | 234 | $0.00 | $0.00 |
Holdings After Transaction:
Non-Qualified Stock Option (right-to-buy) — 525 shares (Direct);
Deferred Stock Unit — 1,354 shares (Direct)
Footnotes (2)
- F1. Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier.
- F2. Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors.
Key Figures
Deferred stock units granted: 234 units
Deferred stock units after grant: 1,354 units
Stock options granted: 525 options
+2 more
5 metrics
Deferred stock units granted
234 units
Grant of deferred stock units on 2026-05-12
Deferred stock units after grant
1,354 units
Total deferred stock units following transaction
Stock options granted
525 options
Non-qualified stock option grant on 2026-05-12
Option exercise price
$533.9200 per share
Non-qualified stock options on common stock
Options expiration
2036-05-11
Expiration date for non-qualified stock options
Key Terms
Deferred Stock Unit, Non-Qualified Stock Option, annual meeting of shareholders, Board of Directors
4 terms
Deferred Stock Unit financial
"Each deferred stock unit represents a contingent right to receive one share of Issuer common stock."
A deferred stock unit (DSU) is a promise from a company to give an employee or director the value of a share at a future date, paid in actual shares or cash when certain conditions are met (such as retirement or a set date). Think of it like a gift card that converts to company stock later; it aligns pay with long‑term performance and can affect future share count, compensation expense and potential cash needs, so investors watch DSUs for their impact on dilution and company finances.
Non-Qualified Stock Option financial
"Grant of option to buy shares of Issuer common stock..."
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Board of Directors financial
"following the date of the Director's resignation from the Board of Directors."
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did Bruce L. Claflin receive from IDEXX (IDXX) in this Form 4?
Bruce L. Claflin received 234 deferred stock units and 525 non-qualified stock options. Each deferred stock unit represents one share of common stock, while the options allow future purchase of 525 shares at a fixed exercise price as part of his director compensation.
What are the vesting terms of Bruce L. Claflin’s new IDEXX (IDXX) equity awards?
Both the deferred stock units and stock options vest in one installment on the one-year anniversary of the grant date or on the date of the 2027 annual shareholders’ meeting, whichever is earlier. This means all granted units and options become exercisable or payable at that single vesting event.
What is the exercise price of Bruce L. Claflin’s new IDEXX (IDXX) stock options?
The non-qualified stock options have an exercise price of $533.9200 per share. This fixed price is what Claflin must pay per share if he chooses to exercise the 525 options after they vest, subject to their stated expiration date in 2036.
How many IDEXX (IDXX) deferred stock units does Bruce L. Claflin hold after this filing?
After the new grant of 234 deferred stock units, Bruce L. Claflin holds a total of 1,354 deferred stock units. Each unit represents a contingent right to receive one share of common stock, generally payable after his resignation from the board of directors.
When are Bruce L. Claflin’s IDEXX (IDXX) deferred stock units payable?
The deferred stock units are, by default, payable in common stock as soon as practicable following the date of Claflin’s resignation from the IDEXX board. This timing links payout to the end of his board service rather than a specific calendar date or market condition.
Do Bruce L. Claflin’s IDEXX (IDXX) Form 4 transactions involve open-market stock purchases or sales?
The transactions reflect grants of deferred stock units and non-qualified stock options, not open-market purchases or sales. They are compensation-related awards granted at a transaction price per unit of $0.0000, separate from any discretionary market trading activity.